Tuning brain fate through modulation of chromatin remodelling
SWItchFate aims to elucidate the role of BAF complexes in brain development and neurodevelopmental disorders using hiPSC-derived organoids and advanced genomic techniques to inform new therapies.
Projectdetails
Introduction
The mammalian SWI/SNF chromatin remodelers, the BAF complexes, are critical regulators of gene expression by modulating the accessibility of regulatory regions, especially of cell identity genes. Their importance for cellular maintenance and differentiation is emphasized by the fact that they are frequently associated with disease.
Disease Association
Mutations in genes encoding BAF subunits are found in over 20% of cancers and are causative for neurodevelopmental disorders (NDD). The prevalence of specific NDD with unique clinical features depends on the mutant subunit. The molecular changes leading to the disease phenotypes are largely unresolved.
Research Objectives
The functions of BAF complexes and specific subunits during human brain development are also still unclear. SWItchFate thus aims to systematically identify the role of individual BAF subunits and their mutations in brain development and abnormalities.
Methodology
To this end, isogenic wild type, mutant, and engineered human induced pluripotent stem cell (hiPSC)-derived cerebral organoids will be used in combination with various bulk and single-cell epigenomics and proteomics tools.
- SWItchFate will investigate gene regulatory mechanisms altered during brain development with CRISPR/Cas-based loss-of-function screens for all BAF subunits.
- Using protein degradation tools targeting specific BAF subunits, SWItchFate will pinpoint vulnerable processes and adaptation mechanisms.
- In addition, cell type- and BAF subtype-specific composition, interaction partners, and target sites along brain development will be mapped to decipher BAF-dependent gene regulatory networks.
Molecular Changes
Finally, the molecular changes in BAF mutation-induced NDD that cause the phenotypic changes in patients will be examined, and conserved mechanisms across different genotypes will be deciphered using patient-derived hiPSC.
Conclusion
Thus, SWItchFate will decode the regulatory functions of BAF complexes in the context of cell fate decisions in development and disease, paving the way for new therapeutics.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.009.474 |
Totale projectbegroting | € 2.009.474 |
Tijdlijn
Startdatum | 1-1-2025 |
Einddatum | 31-12-2029 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- INSTITUT FUR MOLEKULARE BIOLOGIE GGMBHpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Targeting SWI/SNF-related chromatin remodelling defects in solid tumoursThis project aims to uncover and exploit synthetic lethal vulnerabilities in SWI/SNF-deficient tumours to enhance anti-tumour immune responses and develop novel immuno-oncology therapies. | ERC Starting... | € 1.499.887 | 2023 | Details |
Deciphering the role of regulatory factors driving epigenetic inheritance of alternative chromatin statesThe WaddingtonMemory project aims to uncover how Polycomb proteins drive epigenetic inheritance and cell fate changes, using Drosophila and mouse models to establish new paradigms in epigenetics. | ERC Advanced... | € 2.499.764 | 2024 | Details |
Reprogramming of somatic cells into organOids: patient-centred neurodevelopmental disease modelling from nascent induced pluripotencyThe project aims to develop a robust method for generating human brain organoids from patients with Fragile X Syndrome to explore neurodevelopmental phenotypes and inform targeted therapies. | ERC Advanced... | € 2.500.000 | 2023 | Details |
Targeting the Polycomb Machinery in BAP1-related PathologiesThe T-BAP project aims to develop targeted compounds against PRC1.3/5 to restore normal H2Aub1 levels and create therapeutic strategies for cancers linked to BAP1 mutations. | ERC Proof of... | € 150.000 | 2024 | Details |
Deciphering the Regulatory Logic of Cortical DevelopmentEpiCortex aims to map the regulatory landscape of mouse cortical development across timepoints to understand neuronal lineage specification and improve therapeutic strategies for neuropsychiatric diseases. | ERC Consolid... | € 1.999.643 | 2023 | Details |
Targeting SWI/SNF-related chromatin remodelling defects in solid tumours
This project aims to uncover and exploit synthetic lethal vulnerabilities in SWI/SNF-deficient tumours to enhance anti-tumour immune responses and develop novel immuno-oncology therapies.
Deciphering the role of regulatory factors driving epigenetic inheritance of alternative chromatin states
The WaddingtonMemory project aims to uncover how Polycomb proteins drive epigenetic inheritance and cell fate changes, using Drosophila and mouse models to establish new paradigms in epigenetics.
Reprogramming of somatic cells into organOids: patient-centred neurodevelopmental disease modelling from nascent induced pluripotency
The project aims to develop a robust method for generating human brain organoids from patients with Fragile X Syndrome to explore neurodevelopmental phenotypes and inform targeted therapies.
Targeting the Polycomb Machinery in BAP1-related Pathologies
The T-BAP project aims to develop targeted compounds against PRC1.3/5 to restore normal H2Aub1 levels and create therapeutic strategies for cancers linked to BAP1 mutations.
Deciphering the Regulatory Logic of Cortical Development
EpiCortex aims to map the regulatory landscape of mouse cortical development across timepoints to understand neuronal lineage specification and improve therapeutic strategies for neuropsychiatric diseases.